Abzu improved the hit-rate and reduced R&D risk for a top-10 pharmaceutical company
We yielded a 44 percentage point improvement in catching toxic drugs in the drug development pipeline, reducing R&D risk and time.
Abzu yielded a 44 percentage point improvement in catching toxic drugs
The customer: A top-10 pharmaceutical company
Technology + services
Abzu’s flexible packages include our proprietary technology, the QLattice®, and iterative lead generation and optimization.
Revealing the “why” behind disease mechanisms and drug activity drastically reduces risk and timelines in drug development
Flexibility to suit your needs
Enhanced library design